SPDR S&P Biotech ETF $XBI Stock: Geneva Partners LLC Lowers Position

Geneva Partners LLC reduced its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 3.9% during the third quarter, Holdings Channel reports. The firm owned 91,136 shares of the exchange traded fund’s stock after selling 3,693 shares during the period. SPDR S&P Biotech ETF makes up 4.3% of Geneva Partners LLC’s holdings, making the stock its 4th largest holding. Geneva Partners LLC’s holdings in SPDR S&P Biotech ETF were worth $14,370,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Kingswood Wealth Advisors LLC boosted its holdings in SPDR S&P Biotech ETF by 33.7% during the third quarter. Kingswood Wealth Advisors LLC now owns 19,218 shares of the exchange traded fund’s stock worth $3,030,000 after purchasing an additional 4,848 shares during the last quarter. Sigma Planning Corp increased its stake in SPDR S&P Biotech ETF by 525.7% in the 3rd quarter. Sigma Planning Corp now owns 13,077 shares of the exchange traded fund’s stock valued at $2,062,000 after buying an additional 10,987 shares during the last quarter. Compass Ion Advisors LLC increased its stake in SPDR S&P Biotech ETF by 3.0% in the 3rd quarter. Compass Ion Advisors LLC now owns 3,993 shares of the exchange traded fund’s stock valued at $630,000 after buying an additional 117 shares during the last quarter. Citizens Financial Group Inc. RI increased its stake in SPDR S&P Biotech ETF by 3.7% in the 3rd quarter. Citizens Financial Group Inc. RI now owns 7,648 shares of the exchange traded fund’s stock valued at $1,206,000 after buying an additional 276 shares during the last quarter. Finally, Simplicity Wealth LLC lifted its position in shares of SPDR S&P Biotech ETF by 5.3% during the 3rd quarter. Simplicity Wealth LLC now owns 2,513 shares of the exchange traded fund’s stock worth $396,000 after buying an additional 127 shares in the last quarter.

SPDR S&P Biotech ETF Stock Up 0.6%

SPDR S&P Biotech ETF stock opened at $150.47 on Tuesday. SPDR S&P Biotech ETF has a 52 week low of $106.30 and a 52 week high of $169.89. The company’s 50 day moving average price is $157.13 and its two-hundred day moving average price is $140.94. The stock has a market cap of $10.50 billion, a P/E ratio of 11.47 and a beta of 0.83.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.